Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Studies brain structure, brain function and blood gene activity in mental disorders

Observes brain scans and blood gene activity in young people with schizophrenia and healthy controls.

Plain-language title generated from the registry record
Registry title: Psychiatric Multi-omics and Neuroimaging Project

Key facts

Where
Changsha, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 13 and 35 years old?

Source: NCT06580860, who can take part

Where in China

  • The Second Xiangya hospital of central south univerityChangsha, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
mingjun Zhong
Trial code
NCT06580860
Record updated
13 March 2026
Original description
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.Read full original descriptionShow less

Psychiatric Multi-omics and Neuroimaging Project Database

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.

Inclusion: Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age); Course of disease: <24 months; Priority is given to patients who have never taken medicine or duration of drug use < 2 weeks; No nuclear magnetic contraindications.

Exclusion: Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence; Have a major physical disease or infectious disease; History of coma and serious neurological disease 4.MRI contraindications.

ClinicalTrials.gov NCT06580860